Steroid 5-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders

Publisher: Bentham Science Publishers

E-ISSN: 1873-4286|17|2|151-167

ISSN: 1381-6128

Source: Current Pharmaceutical Design, Vol.17, Iss.2, 2011-01, pp. : 151-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract